Cytek Biosciences Inc (CTKB) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.008x

Based on the latest financial reports, Cytek Biosciences Inc (CTKB) has a cash flow conversion efficiency ratio of -0.008x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.74 Million) by net assets ($327.64 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Cytek Biosciences Inc (CTKB) defensive interval to measure how many days the company can operate on defensive assets alone.

Cytek Biosciences Inc - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Cytek Biosciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cytek Biosciences Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cytek Biosciences Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
United States Cellular Corporation
NYSE:USM
-0.100x
Daou Data Corp
KQ:032190
-0.181x
Invesco California Value Muni Inc Tr
NYSE:VCV
0.018x
Chularat Hospital Public Company Limited
BK:CHG
0.028x
Sunrise Energy Metals Ltd
AU:SRL
-0.278x
Capital Bancorp
NASDAQ:CBNK
0.053x
Symphony Limited
NSE:SYMPHONY
0.133x
Si-Bone Inc
NASDAQ:SIBN
-0.013x

Annual Cash Flow Conversion Efficiency for Cytek Biosciences Inc (2019–2025)

The table below shows the annual cash flow conversion efficiency of Cytek Biosciences Inc from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see CTKB company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $341.74 Million $-4.69 Million -0.014x -121.38%
2024-12-31 $395.74 Million $25.38 Million 0.064x +377.33%
2023-12-31 $393.06 Million $5.28 Million 0.013x +146.75%
2022-12-31 $425.55 Million $-12.23 Million -0.029x -351.65%
2021-12-31 $405.38 Million $4.63 Million 0.011x +101.21%
2020-12-31 $-16.03 Million $15.16 Million -0.946x -386.84%
2019-12-31 $-41.70 Million $-13.75 Million 0.330x --

About Cytek Biosciences Inc

NASDAQ:CTKB USA Medical Devices
Market Cap
$513.99 Million
Market Cap Rank
#12273 Global
#3010 in USA
Share Price
$3.98
Change (1 day)
-2.69%
52-Week Range
$2.95 - $5.88
All Time High
$27.93
About

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies usin… Read more